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Abstract
Background: Adequate pain relief at the point of injury and during transport to hospital is a major challenge in all
acute traumas, especially for those with hip fractures, whose injuries are difficult to immobilise and whose long-term
outcomes may be adversely affected by administration of opiate analgesics. Fascia iliaca compartment block (FICB) is a
procedure routinely undertaken by doctors and nurses in the emergency department for patients with hip fracture but
not yet evaluated for use by paramedics at the scene of emergency calls.
In this feasibility study, we aim to test whether FICB administered by paramedics at the scene of participants’ hip fractures
is feasible, safe and acceptable. This will enable us to decide whether to proceed to a fully powered, multi-centre
pragmatic randomised trial to evaluate whether the procedure is effective for patients and worthwhile for the NHS.
Methods/design: In this study, we propose to recruit ten paramedics in an urban area of South Wales. We will train
them to carry out FICB when they attend patients with hip fracture. We will randomly allocate eligible patients to FICB
or usual care using audited scratch cards. We will follow up participants to assess measurability of key outcomes including
quality of life, pain scores, adverse events, length of stay in hospital, acceptability to patients and compliance of
paramedics. We will assess whether the findings meet specified feasibility criteria and, if so, plan a full trial.
Discussion: This study will enable us to recommend whether to undertake a definitive trial of FICB by paramedics for
hip fracture.
Trial registration: ISRCTN60065373
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Background
It is predicted that 6.3 million hip fractures a year will
occur worldwide by 2050 [1]. In the UK, hip fractures
result in more admissions to orthopaedic trauma wards
than patients with any other injury [2]; this has a huge fi-
nancial impact on the National Health Service (NHS) [3].
Hip fracture is associated with a high mortality rate
(30% at 1 year). Delay to surgery—over 48 h—has a
detrimental effect on patient mortality [4–6]. Early surgery
has also been shown to reduce the incidence of post-
operative pneumonia (relative risk 0.59) and pressure
sores (relative risk 0.48) [7]. The National Institute for
Health and Care Excellence [8] therefore advises that
surgery should take place on the day of admission or
the following day.
Prehospital management of patients with hip fracture
can cause severe pain as the injury site is difficult to
immobilise and ambulance staff must move the patient
by lifting and negotiating through obstacles such as
stairs and doorways. Paramedics have a range of avail-
able pain relief options including paracetamol, opiates
and Entonox, with the most frequently administered
being intravenous (IV) morphine [9]. However, several
studies have suggested that prehospital pain relief for
patients with suspected hip fracture is inadequate, with
up to 40% of patients not receiving any pain relief at all
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[10–13]. Following interviews with patients, who believed
their prehospital care could be improved, Aronsson et al.
[14] recommended that alternative methods of pain relief
should be considered before admission to hospital.
Unfortunately, the pharmacokinetics and pharmaco-
dynamics of opiates mean that unpredictable responses
can occur, particularly in the elderly; adverse drug effects
when morphine is administered are therefore likely and
have the potential to delay a patient being taken to theatre
[15]. Rainer et al. [16] showed that IV ketorolac was more
cost-effective than IV morphine in isolated limb injury;
odds of an adverse event with IV morphine were 144
times (95% confidence interval from 41 to 502) more
likely. Alternatives to opiate-based pain relief are there-
fore desirable in the care of hip fracture.
The prehospital management of hip fractures is vital
to provide adequate pain relief, ideally without potential
side effects that may delay surgical fixation and have a
detrimental effect on patient outcomes. We hypothesise
that the use of fascia iliaca compartment block (FICB) to
provide pain relief to patients with a broken hip before
they are taken to the emergency department (ED) may
improve the outcome for patients with hip fracture in
this way.
FICB is increasingly used in ED and orthopaedic wards
in the care of patients with hip fracture. The technique
was first described by Dalens et al. in 1989 [17]. Lees et
al. [18] demonstrated statistically significantly reduced
pain scores in patients receiving FICB in hospital,
compared with controls. Lengths of stay and mortality
rates were also reduced, although there may have been
confounding variables [18]. Increasingly, the evidence
in the literature suggests that FICB is easy to learn,
provides better pain relief and triggers fewer side ef-
fects than opiates [19–26].
The Association of Anaesthetists of Great Britain and
Ireland supports FICB delivered by non-physician practi-
tioners when a physician is not immediately available
[27]. The Association states that non-medical registered
health professionals can perform FICB if they have been
appropriately trained and are following agreed clinical
governance procedures.
Feasibility study aim
The aim of the study is to assess the feasibility of
undertaking a fully powered, multi-centre pragmatic
randomised trial to test the clinical and cost-effectiveness
of paramedics providing FICB as early pain relief for
patients who have fractured a hip at the scene of their
injury.
Feasibility study objectives
To assess:
1. Accuracy of recognition of hip fracture by paramedics
and thus the safety and feasibility of FICB
2. Willingness of both patients and paramedics to
participate in the study
3. Compliance with the FICB protocol by paramedics
4. Sample size required for a full randomised controlled
trial (RCT) and recruitment period required to achieve
this target
5. Acceptability of FICB as method of providing pain
relief in prehospital care of patients with hip fracture
6. Which outcome measures to use in a full RCT and
at what point: for example, pain scores before and
after pain relief; whether the administration of FICB
in prehospital care yields benefits for patients besides
pain relief, notably side effects of opioids (nausea,
constipation, respiratory depression and confusion);
length of time before surgery; and length of stay in
hospital. We shall also assess the ability of participants
to complete forms, the incidence of missing data and
the time taken to complete data collection
7. Whether study processes and outcomes achieve
specified feasibility criteria for trial implementation
Methods/design
Design
Single-centre randomised parallel-group feasibility trial.
Setting
The scenes of patients’ injuries, in the predominantly urban
catchment area of one ED in South Wales, where the
average job cycle time is 90 min.
Paramedic participants
We have recruited ten paramedics based at ambulance
stations in that catchment area and trained them in FICB.
Inclusion criteria
Adult patients (aged 18 years or older) who are:
 Attended out of hospital by a participating
emergency paramedic following a 999 call
 Assessed by the attending paramedic as having an
isolated hip fracture; conscious (Glasgow Coma
Scale score at least 13) and haemodynamically stable
 Conveyed to the participating hospital
We exclude patients if they refuse analgesia or if the
emergency paramedic is working alone without back-up
from the advanced paramedic practitioner, emergency
medical technician or other paramedic.
Sample size
In this randomised feasibility study, we are not seeking
to evaluate FICB and have not therefore undertaken a
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formal power calculation. However, considering that the
participating hospital treated about 370 patients with hip
fracture over 12 months in 2013–2014, and accounting
for shift patterns of paramedics and the number of
patients excluded for other reasons, we estimate that
ten trained paramedics can recruit 50 eligible patients
into the trial over 12 months—enough to assess whether
the trial meets our specified feasibility criteria for progres-
sing to a full trial.
Intervention
Paramedic training
Our proposed training reflects published methods for
training non-medical healthcare professionals [28, 29]
and expert advice from consultants in anaesthetics and
trauma surgery who have previously trained nurses to
carry out FICB in the ED. We train paramedics through
an online package including a video showing the admin-
istration of FICB, followed by group sessions led by a
consultant anaesthetist (SF). Pairs of paramedics then
attend sessions at the participating hospital where they
administer FICB to real patients observed by an anaes-
thetist. They alternate between administering and cri-
tiquing the FICB to ensure their learning is active [30].
The paramedics must pass a competency assessment
before they can recruit patients to the study.
The paramedics will attend a 6-month refresher halfway
through the year of patient recruitment. We advise them to
contact the paramedic research support officer if they feel
they need additional training or support during the recruit-
ment period, typically from the consultant anaesthetist.
Our paramedics routinely measure pain scores on a
numerical rating scale, a standard tool used by health-
care professionals. The patient clinical record used by
paramedics already has a designated box to collect these
data as a standard part of the patient’s assessment. We
therefore provide no additional training for recording
pain scores within this trial.
Treatment protocol
We give paramedics a printed treatment protocol as an
aide mémoire during recruitment. Should a patient be
randomly allocated to receive FICB, the paramedic will
ensure the participant has no contraindication to FICB
including allergy to local anaesthetic; use of anticoagu-
lants; neurovascular damage to the affected leg; previous
femoral bypass surgery; infection at the site of injection;
inability to palpate the femoral artery on the affected leg;
hip prosthesis on the affected side; pregnancy; or body
mass apparently less than 50 kg.
Usual care
At present, paramedics provide a range of analgesia to
patients with hip fracture, including IV morphine,
paracetamol and Entonox [10]. Participants allocated
at random to the control group receive this usual pain
relief, as judged appropriate by the paramedic. To partici-
pants in the intervention group, paramedics can offer
paracetamol and Entonox in addition to FICB. We advise
paramedics not to give morphine for at least 20 min after
patients have received FICB. If FICB has not relieved the
pain after 20 min, however, they can give morphine if they
judge that appropriate.
Randomisation
Before recruiting participants, we produced 100 sequen-
tially numbered scratch cards with concealed trial alloca-
tions generated by the trial statistician (GF). To avoid
subversion of the randomisation procedure, in particular
tampering with the scratch cards, we check that study
paramedics use these scratch cards for eligible patients
in sequence and account for them on their ambulance
stations’ randomisation log. We regularly audit these
logs against the remaining scratch cards.
Patient consent
We take consent in two stages:
1. Consent to treatment: paramedics obtain oral consent
to treatment (i.e. analgesia) according to usual
practise, for example for cannulation or venepuncture.
2. Consent to participation in the trial: An NHS
researcher seeks retrospective consent from patients
to take part in the trial within ten working days of
their injury. This usually occurs in hospital, or in the
community if necessary. For patients with cognitive
impairment, we seek consent to take part in the trial
from relatives or carers. Thus, we recognise that it is
not ethically appropriate to consent patients to
research in a medical emergency [31]. Indeed, in our
SAFER randomised trials in emergency care [32, 33],
we gained ethical information governance and
research approvals to inform patients of their potential
inclusion in research within 10 days of attendance by
emergency ambulance. The PARAMEDIC trial used
similar of enrolling patients, using a waiver of consent
under the Mental Capacity Act, and asking patients for
consent to follow up after this [34]. Consistent with
those trials, all patients who dissent from RAPID then
leave the study.
Study flowchart
All study paramedics keep a laminated copy of the study
flowchart as an aide mémoire (Fig. 1).
Outcomes
We are testing the following outcome measures for the
full RCT:
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Primary
Self-reported:
 Health-related quality of life, using SF-12 [35] at
30 days and 6 months
Routinely collected:
 Mortality at 6 months
Secondary
Self-reported:
 Mobility score, using the Rivermead Mobility Index
at 30 days and 6 months [36]
 Initial pain score at the scene of participants’ injuries
before pain relief, using an 11-point numeric rating
scale with 0 showing no pain at all and 10 showing
the worst pain imaginable [37]
Fig. 1 Study flowchart
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 Satisfaction with care received from paramedics
using a modified Quality of Care Monitor [38]
30 days after the participant’s injury
Routinely collected:
 Length of inpatient stay
 Pain score on arrival in the ED using the same
11-point numeric rating scale [37]
 Participant safety assessed by adverse events (AEs)
occurring in each trial arm, notably their severity,
causality and expectedness
 Duration of paramedic’s management of participant
(‘job cycle time’)
 Use of anti-emetics and alternative analgesia
 Time between arrival at ED and surgery
Qualitative data collection
We will interview ten intervention participants to explore
their experiences of receiving FICB at the scene of their
injury. This will enable us to explore whether this method
of providing analgesia for hip fracture is acceptable to
patients (Study Objective 5). We will sample respondents
purposively [39] to ensure that they cover the range of the
following characteristics:
 Age
 Gender
 Previous hip fracture
 Time of injury
 Study paramedic who treated the participant
We shall record and transcribe these interviews.
Towards the end of the recruitment period, we will
also conduct paramedic focus groups by inviting all ten
trained paramedics to take part. We will explore their
experiences of randomising participants and providing
FICB at the scene of injury (Study Objectives 2 and 3)
and ask how this could work on a larger scale, to aid our
planning of a fully powered RCT.
Data management
We use an electronic data capture and management
system designed for clinical trials, to store anonymised
data securely [40]. We use participants’ contact details
only to arrange interviews and send postal question-
naires and store them on a password-protected com-
puter separate from the trial database. Transcripts of
qualitative interviews and focus groups will have partic-
ipants’ study number but no identifiable information.
We shall also store digital recordings on a password-
protected computer.
Analysis
Quantitative
Quantitative analysis will enable us to assess our data
against the following feasibility criteria [41], which we
seek to meet within reasonable limits:
1. Recruit at least ten paramedics to conduct the trial
2. Paramedics recognise hip fracture with sensitivity of
75% and positive predictive value of 85%
3. At least 50% of intervention participants receive the
intervention
4. At least 60% of recruited participants consent to
follow up
5. Retrieve primary outcomes for at least 70% of
consented participants
6. Mean participant satisfaction in intervention group
is at least 80% of that in control group
7. Clinicians are in equipoise about safety and
effectiveness of paramedic-administered FICB
8. Balance of serious AEs between groups
We base the criteria for progression on direct measures
of a count (criterion 1) and direct measures of proportions
(criteria 3–6). We will use receiver operating characteristic
analysis to generate the positive predictive value (criterion
2) with the first X-ray providing the gold standard.
To judge whether criterion 7 has been met, we shall
compare health-related quality of life, mobility, satisfaction
with care and change in pain scores following analgesia
using t tests of mean scores, mortality risk ratios, median
lengths of inpatient stay, paramedic job cycle time and
time between arrival at ED and surgery using a Wilcoxon
non-parametric test. These exploratory analyses will also
enable us to estimate the sample size for a full trial.
We shall report the results of this feasibility trial accord-
ing to the CONSORT guidelines [42].
Qualitative
We will conduct thematic analysis of data from inter-
views and focus groups. This is a systematic and trans-
parent method of analysis which generates themes from
the implicit and explicit ideas contained in the original
accounts of participants. One researcher will lead the
analysis. Two others, including a lay representative, will
independently monitor key stages of coding, generating
themes and interpretation and adopt a critical stance to
test and confirm findings [43–45].
Lay contribution
Lay representatives with experience and knowledge of
hip fractures and emergency care contributed to devel-
oping the research plan, drafting the application for
funding and preparing all documentation, notably the
Patient Information Sheet. Two lay representatives will
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sit on the Trial Management Group and two others on
the Trial Steering Committee throughout the trial, to
present patients’ perspectives and play a full part in in-
terpretation, reporting and dissemination of findings.
We follow best practise in supporting their contribution
so they collaborate as equal members of the study team
throughout [46, 47].
Discussion
Given the nature of the intervention, it is not possible to
blind paramedics or participants to the treatment they
receive; sham FICB would be unethical. To reduce the
risk of bias in reporting and analysing pain scores, para-
medics record participants’ baseline pain scores before
randomisation. The entire research team except the data
manager will remain blind to participants’ allocations
until the Trial Steering Committee has approved the pri-
mary analysis.
Variable paramedic compliance with the protocol is a
danger. Hence, we shall monitor the following: use of
the randomisation scratch cards to prevent subversion;
missed recruitment of eligible participants; and compli-
ance with study allocation to prevent contamination.
As we randomise participants before they consent,
there is potential for biassed groups if more participants
consent to follow up in one arm of the feasibility study
than the other. Though we do not expect such an imbal-
ance, the data we collect will allow us to assess this risk.
As this feasibility trial has requested volunteers to take
part, they are not necessarily a representative sample of
all the paramedics in the area; we acknowledge that this
is a limitation. If we recommend a fully powered trial of
paramedic-provided FICB, we shall invite all paramedics
in the study areas to take part.
We shall compare outcomes between groups only to
ensure that there are no large differences between groups
and that we remain in equipoise about the clinical effect-
iveness of prehospital paramedic-administered FICB for
hip fracture. We do not aim to evaluate clinical effective-
ness in this feasibility study. Hence, we will interpret ob-
served differences in outcomes between groups with
caution in this underpowered feasibility study.
The findings of this feasibility study will enable us to
recommend whether to conduct a definitive RCT of
FICB by paramedics for hip fracture. If so, we shall prepare
for a fully powered multi-centre trial, notably by liaising
with other ambulance services and EDs to engage further
sites; and drafting a proposal for research funding to
evaluate whether FICB is clinically effective for patients
and cost-effective for the NHS.
Trial status
Ongoing: participant recruitment has commenced.
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